Open AccessEXPERIMENTAL SUBSTANTIATION OF THE USE OF AN ORAL THROMBOLYTIC BASED ON IMMOBILIZED SUBTILISIN AND AN ANTICOAGULANT BASED ON LOW-MOLECULAR-WEIGHT HEPARIN FOR TREATING PULMONARY VASCULAR THROMBOSIS IN COVID-19
Author(s) -
А. А. Чурин,
Е. П. Федорова,
Fomina Ti,
М. В. Филонова,
Marina Soldatova,
N.P. Leonov,
Герман Байкалов,
Kseniya Bakhareva,
П. Г. Мадонов
Publication year - 2022
Publication title -
bûlletenʹ medicinskoj nauki
Language(s) - English
Resource type - Journals
ISSN - 2541-8475
DOI - 10.31684/25418475_2022_1_43
Subject(s) - heparin , thrombosis , medicine , anticoagulant , covid-19 , low molecular weight heparin , oral anticoagulant , subtilisin , pharmacology , cardiology , warfarin , chemistry , biochemistry , atrial fibrillation , enzyme , disease , infectious disease (medical specialty)